Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.0200USD
−7.90 MUSD
70.00 KUSD
180.27 M
About Oncotelic Therapeutics, Inc.
Sector
Industry
CEO
Vuong Trieu
Website
Headquarters
Agoura Hills
Employees (FY)
22
Founded
1988
FIGI
BBG000BJ2VZ6
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OTLC is 0.0361 USD — it has decreased by 11.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Oncotelic Therapeutics, Inc. stocks are traded under the ticker OTLC.
Oncotelic Therapeutics, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
OTLC stock is 16.34% volatile and has beta coefficient of 0.21. Check out the list of the most volatile stocks — is Oncotelic Therapeutics, Inc. there?
Yes, you can track Oncotelic Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
OTLC stock has fallen by 9.75% compared to the previous week, the month change is a 0.55% fall, over the last year Oncotelic Therapeutics, Inc. has showed a 19.78% decrease.
OTLC net income for the last quarter is −735.98 K USD, while the quarter before that showed 115.31 K USD of net income which accounts for −738.27% change. Track more Oncotelic Therapeutics, Inc. financial stats to get the full picture.
Today Oncotelic Therapeutics, Inc. has the market capitalization of 16.31 M, it has decreased by 4.14% over the last week.
No, OTLC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OTLC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncotelic Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 22.00 employees. See our rating of the largest employees — is Oncotelic Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncotelic Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncotelic Therapeutics, Inc. stock shows the sell signal. See more of Oncotelic Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Oncotelic Therapeutics, Inc. EBITDA is −601.86 K USD, and current EBITDA margin is −806.96%. See more stats in Oncotelic Therapeutics, Inc. financial statements.